Drug Price Trends for NDC 81952-0130

Average Pharmacy Cost for 81952-0130

Drug Name	NDC	Price/Unit ($)	Unit	Date
ENOXAPARIN 100 MG/ML SYRINGE	81952-0130-06	9.27693	ML	2025-04-23
ENOXAPARIN 100 MG/ML SYRINGE	81952-0130-06	9.24449	ML	2025-03-19
ENOXAPARIN 100 MG/ML SYRINGE	81952-0130-06	8.86686	ML	2025-02-19
ENOXAPARIN 100 MG/ML SYRINGE	81952-0130-06	8.06611	ML	2025-01-22
ENOXAPARIN 100 MG/ML SYRINGE	81952-0130-06	7.84395	ML	2024-12-18
ENOXAPARIN 100 MG/ML SYRINGE	81952-0130-06	6.55223	ML	2024-11-20
ENOXAPARIN 100 MG/ML SYRINGE	81952-0130-06	9.00454	ML	2024-10-23

Best Wholesale Price for NDC 81952-0130

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for Enoxaparin Sodium (NDC: 81952-0130)

Enoxaparin sodium, a widely used anticoagulant, has been a cornerstone in the prevention and treatment of various thrombotic disorders. As we delve into the market analysis and price projections for this critical medication, specifically focusing on NDC 81952-0130, we'll explore its current market position, future trends, and potential price fluctuations.

Understanding Enoxaparin Sodium

Enoxaparin sodium is a low molecular weight heparin (LMWH) that plays a crucial role in preventing and treating deep vein thrombosis, pulmonary embolism, and other clotting disorders. Its efficacy and safety profile have made it a preferred choice among healthcare providers worldwide.

Current Market Landscape

The global market for enoxaparin sodium has been experiencing steady growth, driven by an aging population and increasing prevalence of cardiovascular diseases. As of 2024, the prefilled syringes market, which includes enoxaparin sodium, is estimated to be worth $3.02 billion[2].

The global prefilled syringes market size is estimated to grow from USD 3,024 million in 2024 to USD 4,972 million by 2035, representing a CAGR of 4.6% during the forecast period 2024-2035.[2]

This growth trajectory suggests a promising future for enoxaparin sodium products, including those under NDC 81952-0130.

Pricing Analysis for NDC 81952-0130

The pricing of enoxaparin sodium can vary based on several factors, including package size, concentration, and market dynamics. For NDC 81952-0130, which specifically refers to the 100mg/1mL prefilled syringe, we have the following pricing information:

Current Pricing

As of the most recent data available, the wholesale price for a package of 10 syringes (NDC 81952-130-06) is $6.55223 per billable unit[6]. This pricing provides a baseline for our projections and market analysis.

Factors Influencing Price

Several factors can influence the price of enoxaparin sodium:

1. Manufacturing costs
2. Supply chain dynamics
3. Regulatory changes
4. Competition from biosimilars
5. Healthcare policies and reimbursement rates

Market Trends and Future Projections

Growing Demand in Emerging Markets

We're seeing an increased demand for prefilled syringes, including enoxaparin sodium, in emerging markets. This trend is particularly notable in the BRICS nations and the Middle East.

We are seeing an increased demand in the emerging markets, particularly within the BRICS nations, namely Brazil, Russia, India, China and South Africa. North Africa and the Middle East also present a similar scenario, characterized by a growth rate of 10-18% for prefilled syringes[2]

This growing demand could potentially lead to increased production and possibly more competitive pricing in the future.

Shift Towards Safety Syringes

The market is showing a clear preference for safety syringes over conventional ones. Currently, safety prefilled syringes capture about 70% of the market share[2]. This trend is likely to continue, potentially affecting the pricing and market position of products like NDC 81952-0130.

Regional Market Dominance

Europe currently holds the majority market share (~50%) in the prefilled syringes market, with this trend expected to continue[2]. However, the Asia-Pacific region is projected to grow at a higher CAGR of 7% during the forecast period of 2024-2035[2]. This shift in regional dynamics could impact global pricing strategies for enoxaparin sodium products.

Competitive Landscape

The enoxaparin sodium market is highly competitive, with several key players vying for market share. NDC 81952-0130, manufactured by Hepalink USA Inc., faces competition from both branded and biosimilar versions of enoxaparin sodium.

Impact of Biosimilars

The introduction of biosimilars has put pressure on pricing in the enoxaparin sodium market. For instance, Redesca and Redesca HP, biosimilars to Lovenox (the original branded enoxaparin sodium), received approval in Canada in 2020[3]. Such approvals in various markets could lead to increased competition and potentially lower prices.

Regulatory Considerations

Regulatory changes can significantly impact the market and pricing of enoxaparin sodium. For instance, the FDA's request for distinct NDC numbers at all levels of labeling for enoxaparin sodium products[4] demonstrates the ongoing regulatory scrutiny in this space.

Price Projections

Based on the current market trends and factors influencing the enoxaparin sodium market, we can make the following price projections for NDC 81952-0130:

1. Short-term (1-2 years): Prices are likely to remain relatively stable, with potential for slight decreases due to increasing competition from biosimilars.

2. Medium-term (3-5 years): We may see a gradual decrease in prices as more biosimilars enter the market and manufacturing processes become more efficient.

3. Long-term (5+ years): Prices could stabilize at a lower point than current levels, but this will depend on factors such as technological advancements in manufacturing, changes in healthcare policies, and overall market demand.

Market Opportunities

Despite potential pricing pressures, there are several opportunities in the enoxaparin sodium market:

1. Expanding indications: Research into new therapeutic applications for enoxaparin sodium could open up new market segments.

2. Innovative delivery systems: Developing more user-friendly or efficient delivery systems could provide a competitive edge.

3. Emerging markets: As healthcare infrastructure improves in developing countries, there's potential for significant market expansion.

4. Personalized medicine: Tailoring dosages and formulations to individual patient needs could create niche market opportunities.

Challenges in the Enoxaparin Sodium Market

While the market for enoxaparin sodium shows promise, there are several challenges to consider:

1. Patent expirations: As patents expire, increased competition from generics and biosimilars could put pressure on prices.

2. Regulatory hurdles: Stringent regulatory requirements can increase costs and time-to-market for new products or formulations.

3. Manufacturing complexities: The production of enoxaparin sodium is complex, which can lead to supply chain vulnerabilities and potential shortages.

4. Healthcare policy changes: Shifts in healthcare policies and reimbursement rates can significantly impact market dynamics and pricing.

Strategies for Market Success

To succeed in this competitive market, manufacturers of enoxaparin sodium products like NDC 81952-0130 should consider the following strategies:

1. Focus on quality and reliability: Maintaining high manufacturing standards can help build trust with healthcare providers and patients.

2. Invest in R&D: Developing improved formulations or delivery systems can provide a competitive edge.

3. Expand global presence: Tapping into emerging markets can offset potential revenue losses in more mature markets.

4. Collaborate with healthcare providers: Building strong relationships with healthcare systems can lead to preferred supplier status.

5. Optimize supply chain: Improving efficiency in production and distribution can help maintain competitive pricing.

Future Outlook

The future of the enoxaparin sodium market, including products like NDC 81952-0130, looks promising despite potential challenges. The growing prevalence of cardiovascular diseases and an aging global population will likely continue to drive demand.

However, manufacturers must stay agile, adapting to changing market conditions, regulatory requirements, and technological advancements to maintain their competitive position.

Key Takeaways

• The global prefilled syringes market, which includes enoxaparin sodium, is projected to grow from $3.02 billion in 2024 to $4.97 billion by 2035.
• Current wholesale pricing for NDC 81952-0130 (100mg/1mL) is $6.55223 per billable unit for a package of 10 syringes.
• Emerging markets, particularly BRICS nations and the Middle East, show significant growth potential for enoxaparin sodium products.
• Safety syringes dominate the market, capturing about 70% of the market share.
• Europe currently leads the prefilled syringes market, but Asia-Pacific is expected to grow at a higher CAGR.
• Biosimilars and regulatory changes are key factors that could influence future pricing and market dynamics.
• Long-term success in the enoxaparin sodium market will require a focus on quality, innovation, global expansion, and supply chain optimization.

FAQs

1. Q: What is the primary use of enoxaparin sodium? A: Enoxaparin sodium is primarily used as an anticoagulant to prevent and treat deep vein thrombosis, pulmonary embolism, and other clotting disorders.

2. Q: How is the pricing of enoxaparin sodium determined? A: Pricing is influenced by factors such as manufacturing costs, supply chain dynamics, regulatory requirements, competition from biosimilars, and healthcare policies.

3. Q: What is the significance of NDC 81952-0130? A: NDC 81952-0130 is the National Drug Code for a specific enoxaparin sodium product, referring to the 100mg/1mL prefilled syringe manufactured by Hepalink USA Inc.

4. Q: How might the entry of biosimilars affect the market for enoxaparin sodium? A: Biosimilars could increase competition, potentially leading to lower prices and changes in market share for existing enoxaparin sodium products.

5. Q: What are the key growth areas for enoxaparin sodium products? A: Emerging markets, particularly in BRICS nations and the Middle East, show significant growth potential. Additionally, the development of improved formulations or delivery systems could open new market opportunities.

Sources cited: [2] https://www.rootsanalysis.com/reports/prefilled-syringes-market/284.html [3] https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00540 [4] https://www.meithealpharma.com/news/42 [6] https://ndclist.com/ndc/81952-130/package/81952-130-06/price